ALB and Sepsis: Not only did these studies show albumin did not increase mortality, but importantly, the SAFE study revealed in its subgroup analysis the use of albumin to be associated with decreased 28-day mortality in severe sepsis, suggesting a potential benefit of albumin use in this population in particular [69].